Clinical trial

Clinical Trial of Dipyridamole in Schizophrenia

NCT00349973

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-05-01

PhaseNA

Study timeline

Study start (unknown)2001-05-01Date precision: month

Registry last updated2019-11-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Schizophreniform Disorderunresolved

Interventions

DipyridamoleDRUG · verified · RxNorm: dipyridamole

OlanzapineOTHER

Sponsors & collaborators

University of Maryland, Baltimorelead sponsor

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00349973 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.